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Abstract 
At the origin, idiopathic hypercalciuria has been 
described as a syndrome consisting of normocalcemia, 
low plasma phosphate levels and abnormally high uri-
nary calcium excretion. The cause of this syndrome was 
subject to many investigations throughout the years. 
Two main pathophysiologic hypotheses have been pro-
posed: a) primary intestinal hyperabsorption of calcium, 
leading to depression of parathyroid hormone (PTH) se-
cretion ("absorptive" hypercalciuria); and b) primary 
renal tubular leak of calcium which stimulates PTH se-
cretion (secondary hyperparathyroidism). Most of the 
published studies indicate that intestinal hyperabsorption 
of calcium with subsequent relative hypoparathyroidism 
is the primary event causing idiopathic hypercalciuria, 
and that this occurs as a consequence of increased pro-
duction of l ,25(OH)i-vitamin D3 (calcitriol). Fasting 
hypercalciuria, originally taken as evidence for a "renal 
leak" of calcium, appears to be, at least in part, the 
consequence of relative hypoparathyroidism. 
Key Words: Calcium renal stone disease, idiopathic 
hypercalciuria, absorptive/renal hypercalciuria, para-
thyroid hormone, calcitriol. 
* Address for correspondence: 
Bernhard Hess 





Telephone No.: 41-31-64 25 25 
FAX No.: 41-31-26 43 60 
403 
Introduction 
Hypercalciuria is defined as a daily urinary excre-
tion of calcium of more than 4 mg/kg body weight (BW) 
( > 0 .1 mmol/kg BW) in either sex ( 11). It can be found 
in nearly 50% of patients with idiopathic calcium neph-
rolithiasis and in about 5 % of normal people (11, 27). 
Hypercalciuria is a familial trait (8) with characteristics 
of autosomal dominant inheritance (24). Since hypercal-
ciuric subjects produce urine which is abnormally super-
saturated with respect to calcium oxalate (36), and since 
lowering urinary calcium concentration by thiazide diu-
retics reduces the activity of nephrolithiasis (10, 38), 
hypercalciuria can be considered as a risk factor for cal-
cium oxalate crystallization and, subsequently, renal 
stone formation (11). It has to be noted, however, that 
for identical standard deviation increments in urinary 
calcium and oxalate concentrations above the normal 
means, the rise in urinary oxalate is much more critical 
for calcium oxalate stone formation than that in urinary 
calcium (33). 
This article reviews idiopathic hypercalciuria, with 
special emphasis on assessment of parathyroid function 
as well as on the production of l ,25(OH)i-vitamin D3 
(calcitriol) in patients affected by this syndrome. 
History of Idiopathic Hypercalciuria 
In 1939, Flocks described 35 patients suffering 
from calcium stones in kidneys or ureters and from 
"slight infection" of the urinary tract (13). When these 
patients were administered a diet with high calcium con-
tent (2500 mg/d), they clearly separated into two groups: 
those (n = 12) whose urinary excretion of calcium re-
mained normal or low ( < 300 mg/d), and those (n = 
23) in whom it was elevated(> 420 mg/d), two of them 
probably having hyperparathyroidism (13). In 1953, 
Albright et al. described a syndrome consisting of nor-
mocalcemia, low plasma phosphorus levels and hypercal-
ciuria in 21 patients in whom the cause of hypercalciuria 
was considered to be "not as yet clear" (1), e.g., no hy-
perparathyroidism, hyperthyroidism, progressing osteo-
porosis, high calcium intake, metastatic malignancy, my-
eloma, sarcoidosis, renal tubular acidosis, or vitamin D 
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Figure l. Pathophysiology of "absorptive" hypercal-
ciuria. Ca = calcium; PTH = parathyroid hormone. 
poisoning were present; the term "idiopathic hypercalci-
uria" (IH) was thus coined (I). 
Five years later, Henneman et al. (16) essentially 
described the same syndrome in 35 patients (including 
the 21 cases originally studied by Albright et al.), in 
comparison with 14 patients with "mild" hyperparathy-
roidism. Although an assessment of parathyroid func-
tion at this time was impossible "unless one has explored 
the neck" (16), the following sequence of events leading 
to IH was postulated: a tubular damage by (staphylococ-
cal) pyelonephritis would result in decreased reabsorp-
tion of calcium, and thus, in hypercalciuria; subsequent-
ly, a tendency towards hypocalcemia would be followed 
by compensatory hyperparathyroidism with consecutive 
hyperphosphaturia and hypophosphatemia (1, 16). The 
concept of "primary renal tubular hypercalciuria" was 
thus born (16). 
However, balance studies in four of Henneman' s 
patients with IH revealed an abnormally low fecal calci-
um excretion (about half the normal value) which only 
could be explained by increased intestinal calcium ab-
sorption, possibly due to "excessive vitamin D activity" 
(16). Actually, studies performed in the sixties did dem-
onstrate elevated intestinal absorption of calcium in pa-
tients with IH, compared with normal controls (3, 12, 
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Figure 2. Pathophysiology of "renal" hypercalciuria. 
For abbreviations, see Fig. I. l,25(OH)iD 3 = cal-
citriol. 
et al. concluded "that the primary disturbance in idio-
pathic hypercalciuria is neither intestinal hyperabsorp-
tion nor urinary hyperexcretion of calcium, but both 
these ... " (23), which perfectly anticipated forthcoming 
studies on the pathophysiology of IH. 
"Absorptive" versus "Renal" Hypercalciuria 
In the early seventies, serum parathyroid hormone 
(PTH) immunoassays became available. In 1973, Coe et 
al. (7) reported that serum PTH levels, measured by a 
radioimmunoassay which detected carboxy- as well as 
amino-terminal PTH fragments, were elevated in 26 out 
of 40 patients with IH; thus, a primary renal leak of 
calcium with secondary hyperparathyroidism in the ma-
jority of cases with IH appeared as a reasonable hypoth-
esis (7). The latter was further supported by studies in 
4 normal volunteers to whom furosemide had been ad-
ministered for 9 days: urinary calcium excretion had 
risen, e.g., hypercalciuria had developed, and serum 
PTH had increased to levels equivalent to those observed 
in patients with IH (7). 
Parathyroid function in idiopathic hypercalciuria 
The dogma of a primary renal leak of calcium in 
IH was challenged one year later (30): based on meas-
urements of PTH (using an antiserum mainly recognizing 
the amino-terminal portion of the PTH molecule) and of 
urinary cAMP as well as fractional absorption of calci-
um from the intestinal tract (orally administered 47Ca) in 
patients with calcium nephrolithiasis on a low calcium 
diet (400 mg/d), Pak et al. (30) demonstrated that pri-
mary intestinal hyperabsorption of calcium was the 
backbone of the IH syndrome in 22 out of 30 stone for-
mers; they thought, however, that both "absorptive" and 
"renal" hypercalciuria might be found as distinct entities 
in patients with IH and calcium renal stones. 
Based on the observed correlation between frac-
tional intestinal calcium absorption and calciuric re-
sponse after oral calcium loading (1 g of calcium), Pak 
et al. subsequently developed a simple test for ambulato-
ry evaluation of the causes of hypercalciuria (31); pa-
tients with normocalcemia, normal fasting and high uri-
nary calcium after calcium loading were called "absorp-
tive" hypercalciurics, whereas those with normocalce-
mia, high fasting urinary calcium and .high fasting uri-
nary cAMP were called "renal" hypercalciurics. In the 
latter group, however, a poor correlation was found be-
tween fractional intestinal absorption of calcium and cal-
ciuric response after oral calcium loading (40). Further-
more, when routinely applied to the clinical evaluation 
of patients with IH and calcium nephrolithiasis, the oral 
calcium loading test appeared to be of limited value, 
since either more than 50% of the patients could not be 
classified as "absorptive" or "renal" hypercalciurics 
(20), or the values largely overlapped in IH and in 
normals (22). 
When carefully considering the regulatory feed-
back mechanisms (11) that occur as a consequence of ei-
ther a primary intestinal hyperabsorption of calcium 
("absorptive" hypercalciuria, Figure 1) or a primary 
renal leak of calcium ("renal" hypercalciuria, Figure 2), 
one realizes that, once steady-state conditions have been 
reached, both sequences of events predict increased in-
testinal absorption and decreased renal tubular reabsorp-
tion of calcium (11). 
Intestinal Absorption of Calcium in Patients with IH 
Since elevated intestinal absorption of calcium ap-
pears to occur in "absorptive" as well as in "renal" hy-
percalciuria (Figures 1 and 2), it is not surprising that 
comparative studies carried out in patients with IH and 
in normal controls unequivocally found such increased 
fractional intestinal absorption of calcium in IH (3, 12, 
19, 23, 29, 30, 34, 37), irrespective whether (19, 29, 
30) or not (3, 12, 23, 34, 37) patients were subdivided 
into "absorptive" and "renal" hypercalciurics. 
From a theoretical standpoint, at that time, intes-
tinal hyperabsorption of calcium could have been envi-
sioned as calcitriol-dependent or calcitriol-independent. 
Over the years, however, refinement of calcitriol assays 
allowed to obtain substantial evidence in favor of the 
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former. Indeed, as summarized in Table 1, numerous 
studies have clearly demonstrated increased or high-nor-
mal, but neither decreased nor low-normal serum levels 
of calcitriol in IH, irrespective of its "absorptive" or 
"renal" origin (2, 5, 15, 19, 34, 39); in other studies, 
serum calcitriol was at least up-regulated in the face of 
the status of its modulators, namely blood ionized cal-
cium (9), phosphate (2) and PTH (9) concentrations. 
This points to a disturbed control of calcitriol synthe-
sis (2, 11, 18) in patients with IH, with subsequent de-
pression of PTH synthesis. Alternatively, one may envi-
sion increased sensitivity of the intestine and/or the 
parathyroid glands to calcitriol. Indeed, Silver et al. 
(35) have demonstrated that calcitriol decreases the 
transcription of the PTH gene and, subsequently, lowers 
PTH synthesis. 
Parathyroid Function in Patients with IH 
As postulated by Coe and Bushinsky (11), a pri-
mary increase in calcitriol synthesis would lead to low 
or low-normal PTH values in steady-state measurements, 
whereas a primary renal leak of calcium would tend to 
raise serum PTH values (secondary hyperparathyroid-
ism). However, with exception of the original article by 
Coe et al. (7), as well as in part of the reports by Pak et 
al. (30), Bordier et al. (4) and Pak and Galosy (32), 
none of the published studies (2, 5, 6, 9, 15, 25, 28) 
ever confirmed the existence of secondary hyperparathy-
roidism in patients with IH. On the contrary, the vast 
majority of published data indicates normal (2, 6, 28) or 
even decreased (5, 9, 15, 25, 34) fasting blood levels of 
PTH levels in patients with IH, compared with healthy 
controls (Table 2). Recently, using a sensitive immuno-
radiometric assay to detect the intact PTH molecule, we 
confirmed the occurrence of relative hypoparathyroid-
ism in male hypercalciurics with recurrent idiopathic 
calcium nephrolithiasis in comparison with normocalci-
uric calcium renal stone formers; furthermore, urinary 
excretion rates of urea and sulfate, markers of protein 
consumption, were significantly higher in hypercalciuric 
stone formers (17). It remains to be seen to what extent 
increased protein consumption, a known dietary risk fac-
tor for idiopathic hypercalciuria (14), may be related to 
the up-regulation of calcitriol and the subsequent relative 
hypoparathyroidism that can be observed in hypercalci-
uric calcium renal stone formers (17). 
Fasting Hypercalciuria 
Fasting hypercalciuria has been thought to indi-
cate a primary renal tubular leak of calcium (31). How-
ever, it could equally well be the consequence of relative 
hypoparathyroidism in IH. As demonstrated by Broadus 
et al. (5), there is a significant negative correlation be-
tween fasting urinary calcium excretion and parathyroid 
function, based on measurements of urinary cyclic AMP, 
a phenomenon that the intact PTH assay helped us to 
confirm (17). Thus, the ever-observed renal leak of cal-
cium in some patients with IH could just have an hormo-
nal basis (5). 
B. Hess and Ph. Jaeger 
Table 1. Plasma calcitriol in patients with hypercalci-
uria (HC) and calcium nephrolithiasis. 
















n Mean plasma calcitriol t Ref.No. 
26 + 72 
15 + 59 
21 + 32 
3 + 103 
11 + 113 
10 + 53 
24 + 18 
50 + 64 
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In addition, dietary NaCl intake appears to be a 
determinant not only of daily, but also of fasting hyper-
calciuria. Indeed, an increase in dietary NaCl consump-
tion lowers calcium reabsorption along the renal tubule 
(14), thus inducing with some time lag fasting hypercal-
ciuria (21, 26). Since not all patients with recurrent 
calcium nephrolithiasis seem to consume NaCl in excess 
(14), undue sensitivity to the calciuric stimulus of NaCl 
has been postulated in these patients (14, 21). 
Summary 
Altogether, available data strongly suggest that 
the syndrome of IH includes features of both intestinal 
hyperabsorption and reduced renal tubular reabsorption 
of calcium (9, 23). There seems to be convincing evi-
dence, however, for a primary increase in calcitriol pro-
duction in patients with IH; alternatively, increased sen-
sitivity of the intestine and/or the parathyroid glands to 
normal calcitriol levels might be present in some patients 
with IH. Both will depress PTH synthesis and induce 
relative hypoparathyroidism. The latter directly contrib-
utes to hypercalciuria, i.e., the lower PTH secretion, the 
higher urinary calcium excretion (Figure 3). A substan-
tial body of evidence supports the view that "absorptive" 
and "renal" hypercalciuria are not distinctive entities, 
but rather two extremes of a continuum behavior (9): 
"absorptive" hypercalciuria will be found in patients in 
whom a night of fast suffices to finalize calcium absorp-
tion and elimination and to return PTH secretion to nor-
mal, whereas "renal" hypercalciuria will be found in 
those patients whose PTH suppression and ensuing renal 
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Table 2. Serum PTH in patients with hypercalciuria 
(HC) and calcium nephrolithiasis. 
Type of HC n Mean plasma calcitriol t Ref.No. 
1H 40 + 55• 7 
"AH" 22 - 33 30 
"RH" 2 + 198 
"RH" 9 + 30• 4 
1H 26 - 3 15 
1H 15 - 33 34 
"AH" 51 - 47 32 
"RH" 20 + 172 
1H 41 - 41 25 
1H 24 - 28 9 
"AH" 15 - 60* 28 
11RH 11 21 - 54• 
1H 42 - 16 2 
For abbreviation definitions, see Table 1. 
• = % deviation from indicated upper limit of normal 
range of PTH values (no healthy controls studied). 
t Calcitriol I 
t sens. to calcitriol 
◊ 






t Uca XV 
Figure 3. Sequence of events leading to hypercalciuria. 
Uca x V = 24-hour urine excretion of calcium. For 
other abbreviations, see Fig. 1. 
Parathyroid function in idiopathic hypercalciuria 
leakage of calcium last longer. Whether a particular 
patient is an "absorptive" or "renal" (fasting) hypercalci-
uric probably depends, at least in part, also on dietary 
factors, such as NaCl consumption. 
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propriately addressed by text changes, hence there is no 
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